Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States - a podcast by Clinical Care Options
from 2022-05-04T05:02:28.906430
In this episode, Petros Grivas, MD, PhD, and Jonathan E. Rosenberg, MD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma informing their clinical practice in the United States. Topics include:
 Presenters: Petros Grivas, MD, PhD Jonathan E. Rosenberg MD Content based on an online IME program supported by educational grants from Pfizer and EMD Serono, Inc. Link to full program, including associated downloadable slidesets and on-demand Webcast: |
Further episodes of CCO Oncology Podcast
Further podcasts by Clinical Care Options
Website of Clinical Care Options